COVID - 19 Vaccination Update - Day 526 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 25 JUN 2022 8:33PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 197 Crore(1,97,06,96,547)landmark milestone today. More than 11 lakh (11,19,043) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10408690
	2^nd Dose	10061578
	Precaution Dose	5627804
FLWs	1^st Dose	18423084
	2^nd Dose	17620789
	Precaution Dose	10002596
Age Group 12-14 years	1^st Dose	36301191
	2^nd Dose	22540714
Age Group 15-18 years	1^st Dose	60302507
	2^nd Dose	48359207
Age Group 18-44 years	1^st Dose	558106777
	2^nd Dose	500092127
	Precaution Dose	2529942
Age Group 45-59 years	1^st Dose	203422699
	2^nd Dose	193168273
	Precaution Dose	2348713
Over 60 years	1^st Dose	127233904
	2^nd Dose	120637211
	Precaution Dose	23508741
Cumulative 1^st dose administered		1014198852
Cumulative 2^nd dose administered		912479899
Precaution Dose		44017796
Total		1970696547

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 25^thJune, 2022 (526^thDay)
HCWs	1^st Dose	48
	2^nd Dose	560
	Precaution Dose	15020
FLWs	1^st Dose	160
	2^nd Dose	1320
	Precaution Dose	58871
Age Group 12-14 years	1^st Dose	70191
	2^nd Dose	184437
Age Group 15-18 years	1^st Dose	26056
	2^nd Dose	68944
Age Group 18-44 years	1^st Dose	32240
	2^nd Dose	249204
	Precaution Dose	117667
Age Group 45-59 years	1^st Dose	6415
	2^nd Dose	59028
	Precaution Dose	52496
Over 60 years	1^st Dose	4348
	2^nd Dose	42057
	Precaution Dose	129981
Cumulative 1^st dose administered		139458
Cumulative 2^nd dose administered		605550
Precaution Dose		374035
Total		1119043

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.